Under current statutory provisions, the ability of creditors to weaponize consumer credit reports to coerce the payment of medical debt has been heavily curtailed in New Jersey. Recognizing that medical debt is generally a poor indicator of overall creditworthiness or financial responsibility, the Louisa Carman Medical Debt Relief Act strictly prohibits medical creditors and debt collectors from reporting any medical debt to consumer reporting agencies (CRAs) for health care services performed on or after the law’s effective date of July 22, 2024.

For healthcare services performed prior to that date, the law provides retroactive protection for specific balances. Consumer reporting agencies are legally prohibited from including any paid medical debt, or any active medical debt under $500, on a consumer credit report, regardless of the date the debt was originally incurred. This state-level mandate aligns with, and in some aspects exceeds, the voluntary standards adopted by the major national credit reporting agencies—Experian, Equifax, and TransUnion—following intensive federal regulatory pressure from the Consumer Financial Protection Bureau (CFPB). The CFPB has consistently noted that medical billing is fraught with complexity, leading to profound consumer confusion and unwarranted credit damage.

The enforcement mechanisms securing these reporting bans are extraordinarily robust. Any medical debt that is furnished to a consumer reporting agency in violation of these provisions is statutorily declared “void”. This means that if a debt collector illegally reports a protected medical debt to coerce payment, the underlying legal obligation to pay that debt is completely invalidated. Furthermore, the creditor may be subject to severe civil penalties enforced by the Office of the Attorney General, including orders to repay money or property acquired through illegal leverage. Notably, this prohibition applies seamlessly downstream; the Act mandates that any sale of medical debt to a third-party junk debt buyer must include a legally binding written agreement prohibiting the buyer from reporting the information to CRAs. These concerted actions are projected to elevate the credit scores of millions of impacted residents, restoring their access to equitable mortgage and auto lending markets.